These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 13104328)

  • 1. Toxic effects of 1-hydrazinophthalazine in ambulatory hypertensive patients.
    WALD MH; FIERRO MI; KEETON KH
    Am Heart J; 1953 Dec; 46(6):861-4. PubMed ID: 13104328
    [No Abstract]   [Full Text] [Related]  

  • 2. Death associated with hexamethonium and 1-hydrazinophthalazine (apresoline) therapy.
    KLAYMAN MI; SILBERG NR; KARLEN WS
    N Engl J Med; 1953 Jun; 248(26):1109-11. PubMed ID: 13054899
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute psychosis as a complication of hydralazine therapy in essential hypertension.
    MOSER M; SYNER J; MALITZ S; MATTINGLY TW
    J Am Med Assoc; 1953 Aug; 152(14):1329-31. PubMed ID: 13061271
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute systemic lupus erythematosus syndrome from hydralazine hydrochloride.
    HENN MJ; PARKIN TW; HARGRAVES MM; ODEL HM
    AMA Arch Intern Med; 1955 Jun; 95(6):857-62. PubMed ID: 14375421
    [No Abstract]   [Full Text] [Related]  

  • 5. Syndrome simulating collagen disease caused by hydralazine (Apresoline).
    PERRY HM; SCHROEDER HA
    J Am Med Assoc; 1954 Feb; 154(8):670-3. PubMed ID: 13117684
    [No Abstract]   [Full Text] [Related]  

  • 6. Rheumatic and febrile syndrome during prolonged hydralazine treatment.
    DUSTAN HP; TAYLOR RD; CORCORAN AC
    J Am Med Assoc; 1954 Jan; 154(1):23-9. PubMed ID: 13108653
    [No Abstract]   [Full Text] [Related]  

  • 7. Bleeding peptic ulcer complicating hydralazine and hexamethonium bromide therapy.
    MANDELBAUM H; BROOK J; MANDELBAUM RA
    J Am Med Assoc; 1954 Jun; 155(9):833-5. PubMed ID: 13162812
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of 1-hydrazinophthalazine on cerebral blood flow, vascular resistance, oxygen uptake and jugular oxygen tension in hypertensive subjects.
    HAFKENSCHIEL JH; FRIEDLAND CK
    J Clin Invest; 1953 Jul; 32(7):655-60. PubMed ID: 13069612
    [No Abstract]   [Full Text] [Related]  

  • 9. Fatal reaction to 1-hydrazinophthalazine (apresoline).
    COHEN BM
    Am Heart J; 1953 Jun; 45(6):931-5. PubMed ID: 13050605
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of l-hydrazinophthalazine (apresoline) in treatment of hypertensive disease.
    TAYLOR RD; DUSTAN HP; CORCORAN AC; PAGE IH
    AMA Arch Intern Med; 1952 Dec; 90(6):734-49. PubMed ID: 12996103
    [No Abstract]   [Full Text] [Related]  

  • 11. 1-Hydrazinophthalazine (apresoline) in the treatment of hypertensive disease: a clinical trial with a control group.
    MERRILL DH; KENYON K
    Am J Med Sci; 1953 Dec; 226(6):623-31. PubMed ID: 13104414
    [No Abstract]   [Full Text] [Related]  

  • 12. Pancytopenia following use of hydrallazine (apresoline).
    KAUFMAN M
    J Am Med Assoc; 1953 Apr; 151(17):1488-90. PubMed ID: 13034502
    [No Abstract]   [Full Text] [Related]  

  • 13. Late reaction to hydralazine (Apresoline) therapy.
    MANTER WB
    N Engl J Med; 1954 May; 250(19):835-6. PubMed ID: 13165907
    [No Abstract]   [Full Text] [Related]  

  • 14. Apresoline intolerance with bladder paralysis.
    Laurence DR; Miles NA
    N Engl J Med; 1953 Mar; 248(11):464-5. PubMed ID: 13036976
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemodynamic effects of 1-hydrazinophthalazine in patients with arterial hypertension.
    ROWE GG; HUSTON JH; MAXWELL GM; CROSLEY AP; CRUMPTON CW
    J Clin Invest; 1955 Jan; 34(1):115-20. PubMed ID: 13221661
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of oral 1-hydrazinophthalazine therapy on renal function in essential vascular hypertension.
    MADER IJ; ISERI L
    Am Heart J; 1955 Oct; 50(4):556-66. PubMed ID: 13258483
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of hydrazinophthalazine on intrarenal hemodynamics in essential hypertension].
    DOERING P; KOCH R; KUHNS K; SCHWAB M
    Dtsch Arch Klin Med; 1954; 201(1):44-56. PubMed ID: 13173294
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy of hypertension with hydrazinophthalazine].
    KUHNS K; MEYER-HOFMANN G; HOPFNER K
    Klin Wochenschr; 1953 Aug; 31(29-30):690-4. PubMed ID: 13097882
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of hydrazinophthalazine in essential hypertension].
    VIZZINI AA
    Hospital (Rio J); 1953 Dec; 44(6):775-82. PubMed ID: 13151634
    [No Abstract]   [Full Text] [Related]  

  • 20. 1-Hydrazinophthalazine (apresoline) in hypertension.
    HARRIS E; TURNER R
    Lancet; 1954 Feb; 266(6809):429-33. PubMed ID: 13131873
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.